ATE89740T1 - Verfahren zur herstellung und zusammensetzungen von kollagen-derivaten. - Google Patents

Verfahren zur herstellung und zusammensetzungen von kollagen-derivaten.

Info

Publication number
ATE89740T1
ATE89740T1 AT88312264T AT88312264T ATE89740T1 AT E89740 T1 ATE89740 T1 AT E89740T1 AT 88312264 T AT88312264 T AT 88312264T AT 88312264 T AT88312264 T AT 88312264T AT E89740 T1 ATE89740 T1 AT E89740T1
Authority
AT
Austria
Prior art keywords
compositions
preparation
methods
collagen
collagen derivatives
Prior art date
Application number
AT88312264T
Other languages
English (en)
Inventor
Shmuel Shoshan
Shlomo Magdassi
Dov Michaeli
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of ATE89740T1 publication Critical patent/ATE89740T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0033—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT88312264T 1987-12-22 1988-12-22 Verfahren zur herstellung und zusammensetzungen von kollagen-derivaten. ATE89740T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL84911A IL84911A (en) 1987-12-22 1987-12-22 Processes for the preparation of collagen products, and pharmaceutical compositions containing the same
EP88312264A EP0322249B1 (de) 1987-12-22 1988-12-22 Verfahren zur Herstellung und Zusammensetzungen von Kollagen-Derivaten

Publications (1)

Publication Number Publication Date
ATE89740T1 true ATE89740T1 (de) 1993-06-15

Family

ID=11058409

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88312264T ATE89740T1 (de) 1987-12-22 1988-12-22 Verfahren zur herstellung und zusammensetzungen von kollagen-derivaten.

Country Status (5)

Country Link
US (1) US5073378A (de)
EP (1) EP0322249B1 (de)
AT (1) ATE89740T1 (de)
DE (1) DE3881364T2 (de)
IL (1) IL84911A (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071655A (en) * 1990-01-12 1991-12-10 Baylink David J Pharmaceutical combination for treatment of bone-wasting diseases
US5364839A (en) * 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
US5955436A (en) * 1990-11-20 1999-09-21 Alcon Laboratories, Inc. Use of platelet derived growth factor to enhance wound healing
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
DE59209889D1 (de) * 1991-09-13 2001-03-01 David J Baylink Knochenwachstumsfördernde zusammensetzung
WO1993018748A1 (en) * 1992-03-19 1993-09-30 Allergan, Inc. Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
US5660857A (en) * 1993-03-22 1997-08-26 Johnson & Johnson Medical Inc. Biopolymer composites
JPH08508511A (ja) * 1993-04-29 1996-09-10 ワシントン・ユニバーシテイー 副行循環の改善への血小板由来成長因子の使用
FR2710840B1 (fr) * 1993-10-04 1995-12-01 Applic Transferts Technolo Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
WO1998031403A1 (en) * 1997-01-16 1998-07-23 Cohesion Corporation Lyophilized collagen-based biomaterials, process of preparation and uses thereof
WO2002070024A1 (en) 2001-01-04 2002-09-12 Osteotech, Inc. Method for sterilizing bioactive materials
DE102004018347A1 (de) * 2004-04-06 2005-10-27 Manfred Dr. Schmolz Wundheilungsfördende Botenstoffmischung
ATE425765T1 (de) 2005-10-20 2009-04-15 Filippo Ernestino Parodi Verwendung von kollagen in kombination mit sauerstoff- und ozon-freisetzenden perfluorkohlenwasserstoffen zur herstellung eines medikaments zur behandlung von hautverletzungen
US20080023871A1 (en) * 2006-07-28 2008-01-31 Gm Global Technology Operations, Inc. Methods of forming polymeric articles having continuous support structures
US9555171B2 (en) 2010-09-30 2017-01-31 Depuy Mitek, Llc Methods and devices for collecting separate components of whole blood
CN102949709B (zh) * 2011-08-18 2014-02-26 中国科学院大连化学物理研究所 一种治疗糖尿病足的外用凝胶剂及制备和应用
WO2014147622A1 (en) * 2013-03-21 2014-09-25 Collplant Ltd. Compositions comprising collagen and prp for tissue regeneration
HK1194912A2 (en) * 2013-09-17 2014-10-24 Bestop Group Holdings Ltd Growth factor concentrate and the use thereof
US20150216947A1 (en) * 2014-02-03 2015-08-06 George D. Petito Method and composition for tissue/cell repair
US9585943B2 (en) 2014-02-03 2017-03-07 George D. Petito Composition for tissue/cell repair
US9539363B2 (en) 2014-04-24 2017-01-10 Warsaw Orthopedic, Inc. Collagen matrix
CN111295094A (zh) 2017-10-09 2020-06-16 泰尔茂比司特生物技术有限公司 冻干容器及使用冻干容器的方法
EP3666298A1 (de) * 2018-12-13 2020-06-17 Global Stem Cell Technology Zur injektion geeignete kollagenformulierung
CA3130700A1 (en) 2019-03-14 2020-09-17 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
CN114591419B (zh) * 2022-03-07 2022-09-23 山东大学 一种热水解蛋白及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002739A (en) * 1975-02-18 1977-01-11 Warner-Lambert Company Soluble collagen
US4105798A (en) * 1976-07-19 1978-08-08 Sun Ventures, Inc. Perfluoro polycyclic compounds for use as synthetic blood and perfusion media
EP0031353B1 (de) * 1979-06-25 1984-08-08 Suntech, Inc. Verwendung von perfluorkohlenstoff bei der behandlung von verbrennungen
US4347243A (en) * 1979-10-04 1982-08-31 Research Corporation Acid soluble, pepsin resistant platelet aggregating material
US4374830A (en) * 1979-10-04 1983-02-22 Research Corp. Platelet aggregating material from equine arterial tissue
US4789663A (en) * 1984-07-06 1988-12-06 Collagen Corporation Methods of bone repair using collagen
CA1259914A (en) * 1984-07-06 1989-09-26 Donald G. Wallace Methods of bone repair using collagen
EP0383363A3 (de) * 1984-11-29 1990-10-03 Regents Of The University Of Minnesota Verwendung von Wundheilungsagentien
CA1294546C (en) * 1986-04-23 1992-01-21 John S. Sundsmo Wound healing composition containing collagen
US4760131A (en) * 1986-04-23 1988-07-26 Collagen Corporation Wound-healing composition

Also Published As

Publication number Publication date
EP0322249A3 (en) 1990-03-28
EP0322249A2 (de) 1989-06-28
EP0322249B1 (de) 1993-05-26
IL84911A (en) 1993-04-04
US5073378A (en) 1991-12-17
DE3881364D1 (de) 1993-07-01
IL84911A0 (en) 1988-06-30
DE3881364T2 (de) 1993-11-25

Similar Documents

Publication Publication Date Title
ATE89740T1 (de) Verfahren zur herstellung und zusammensetzungen von kollagen-derivaten.
ATE187646T1 (de) Verwendung von kupfer enthaltenden wirkstoffen zur beschleunigung der wundheilung
DE3855113D1 (de) Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
ATE126433T1 (de) Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen.
ATE120960T1 (de) Stabile injizierbare lösungen von faktor viii.
DE3689056D1 (de) Verfahren und Zusammensetzung zur Herstellung von Liposomen.
DK485788A (da) Kosmetisk praeparat
DE58906574D1 (de) Verfahren zur Herstellung von cyclischen Kohlensäureestern.
DE69129899D1 (de) Verfahren zur Herstellung von D-Alpha-Aminosäuren
DE3869230D1 (de) Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin.
DE3888251D1 (de) Verfahren zur Herstellung von Metallsalzen von Phosphor- und Phosphonsäureestern.
ES2038733T3 (es) Procedimiento para preparar una solucion inyectable de la sal de acido tioctico con trometanol y/o aminoacidos basicos.
DE69315388D1 (de) Aus bakteriellen Proteinen bestehender Extrakt, Verfahren zur dessen Herstellung und diesen Extrakt enthaltende pharmazeutische Zusammensetzung
DE68924011D1 (de) Verfahren zur Herstellung von Pyrazolkarbonsäure und Derivaten.
DE59004490D1 (de) Verfahren zur Herstellung von alpha-Fluoracrylsäurederivaten.
DE59200056D1 (de) Verfahren zur Herstellung von beta-Ketocarbonsäureestern.
DE69016065D1 (de) Verfahren zur Herstellung von Calciumsalzen von Fettsäuren.
ATE76636T1 (de) Verfahren zur herstellung von benzoesaeure und ihren salzen.
DE58903876D1 (de) Riboflavin-4'5'-cyclo-phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz.
DE3850230D1 (de) Verfahren zur Herstellung von Alkylthioethylaminsalzen.
NO883520L (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
DE68923836D1 (de) Verfahren zur Herstellung von wässrigen Zusammensetzungen von Silikonelastomeren.
DE59104571D1 (de) Verfahren zur Herstellung von Vinylphosphonsäurederivaten.
ATE94905T1 (de) Verfahren zur herstellung von fremdproteinen in streptomyceten.
DE3850601D1 (de) Verfahren zur Herstellung von Phospholipidderivate.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties